These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 11891537

  • 1. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L, Chen J, Du Q, Dumanski J, Blennow E, Kockum I, Luthman H, Lindblom A.
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [Abstract] [Full Text] [Related]

  • 2. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L, Lindblom A.
    Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 4. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
    Tseng SL, Yu IC, Yue CT, Chang SF, Chang TM, Wu CW, Shen CY.
    Genes Chromosomes Cancer; 1997 Dec 01; 20(4):377-82. PubMed ID: 9408754
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN, Presneau N, Provencher D, Mes-Masson AM, Tonin PN.
    Mol Carcinog; 2002 Jun 01; 34(2):78-90. PubMed ID: 12112314
    [Abstract] [Full Text] [Related]

  • 6. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G, Barkardottir RB, Agnarsson BA, Johannesdottir G, Olafsdottir K, Egilsson V, Ingvarsson S.
    Oncogene; 1998 Jan 08; 16(1):21-6. PubMed ID: 9467939
    [Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec 08; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 8. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P.
    Clin Cancer Res; 2006 Mar 15; 12(6):1693-700. PubMed ID: 16551851
    [Abstract] [Full Text] [Related]

  • 9. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S.
    J Pathol; 2001 Jul 15; 194(3):318-26. PubMed ID: 11439364
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ, Chen H, Rubin MA, Wojno KJ, Cooney KA.
    Cancer Res; 2001 Dec 15; 61(24):8651-3. PubMed ID: 11751379
    [Abstract] [Full Text] [Related]

  • 11. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.
    Hum Mutat; 2005 Mar 15; 25(3):319. PubMed ID: 15712267
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R, Hussain I, Afroze D, Aejazaziz S, Jan M, Shah ZA, Das BC, Siddiqi MA.
    Cancer Lett; 2007 Apr 18; 248(2):308-20. PubMed ID: 16996204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L, Brognara I, Baiocchi D, Amadori D, Gasperi-Campani A.
    Oncol Rep; 2005 Aug 18; 14(2):471-4. PubMed ID: 16012732
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 17. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C.
    Cancer Res; 1998 Mar 01; 58(5):1004-12. PubMed ID: 9500463
    [Abstract] [Full Text] [Related]

  • 18. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.
    Rhiem K, Todt U, Wappenschmidt B, Klein A, Wardelmann E, Schmutzler RK.
    Anticancer Res; 2010 Sep 01; 30(9):3445-9. PubMed ID: 20944121
    [Abstract] [Full Text] [Related]

  • 19. Loss of heterozygosity in familial breast carcinomas.
    Lindblom A, Skoog L, Rotstein S, Werelius B, Larsson C, Nordenskjöld M.
    Cancer Res; 1993 Sep 15; 53(18):4356-61. PubMed ID: 8364930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.